GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (LSE:OXB) » Definitions » Price-to-Funds-From-Operations

Oxford BioMedica (LSE:OXB) Price-to-Funds-From-Operations : (As of Jan. 19, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Oxford BioMedica Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Oxford BioMedica Business Description

Industry
Traded in Other Exchanges
Address
Windrush Court, Transport Way, Oxford, GBR, OX4 6LT
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types.